PCOS and Hirsuitism Flashcards

1
Q

What are Virilisation and Hirsutism?

A
  • Virilisation: Extreme manifestations of androgen exposure, e.g. temporal hair recession, clitoromegaly, increased muscle mass, breast atrophy, deepening of voice
  • Hirsutism: Hair growth in areas usually associated with male sexual maturity, e.g. face, lower abdomen, anterior thigh, periareolar region
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What factors make up Polycystic Ovarian Syndrome?

A
  • Hyperandrogenism (e.g. acne and hirsutism)
  • Anovulation (typically amen/oligomenorrhoea)
  • Appearance of polycystic ovaries on ultrasound
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the Epidemiology of PCOS?

A
  • Affects 20% of Caucasian women, more common e.g. Hispanic Americans or UK Asians
  • Considered to arise during puberty and associated with obesity in ~40% of cases
  • Cost US Health Economy $4.4 billion in 2005 - 4 million women (6.6% of reproductive aged women, 1990 NIH criteria)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are clinical features of PCOS?

A
  • Oligo/Amenorrhoea (Anovulatory cycles, Dysfunctional uterine bleeding, Infertility)
  • Androgenisation (Hirsutism, Acne, Male pattern hair loss)
  • Acanthosis nigricans
  • Obesity (30-75%)
  • IGT (30-40%) and T2DM (10%)
  • Hypertension/vascular dysfunction
  • Obstructive sleep apnoea (44-70%)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the International evidence-based guideline for the asessment and mangement of PCOS?

A
  • When irregular menstrual cycles are present a diagnosis of PCOS should be considered
  • Calculated free testosterone, FAI or bioavailable testosterone should be used to assess biochemical hyperandrogenism
  • LCMS or extraction/chromatography immunoassays, should be used for assessment of testosterone
  • Consider androstenedione and DHEAS if normal total or free testosterone
  • Where androgen levels are markedly elevated, other causes of biochemical hyperandrogenism need to be considered
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the conditions with features overlapping PCOS?

A

Familial/Idiopathic Hirsutism: Non-androgenic pattern of hair growth

Pregnancy: Amenorrhoea, weight gain.

  • Useful test: Urine/serum HCG is a test for differentiation

Hypothalamic Amenorrhoea: Amenorrhoea, low BMI, excessive exercise. Lack of clinical features of androgen excess, PCO sometimes present

  • Useful test: LH, FSH, E2

Primary Ovarian Insufficiency: Amenorrhoea and Symptoms of oestrogen deficiency.

  • Useful test: FSH​, E2

History of drug therapy

Steroid pathway defects: Lower likelihood of anovulation and PCO prevalence (24%) than in PCOS (90%)

  • Useful Test: Urine steroid metabolites, 17-OHP (basal + stimulated)

Prolactin excess

  • Useful test: Prolactin (↑ in 10-25% of PCOS)

Thyroid disorders: ↑ ovarian volume and cystic changes reported in primary hypothyroidism

  • Useful test: TFTs

Cushing’s syndrome: 70-80% menstrual abnormalities, 46% PCO. Prevalent hirsutism (100% low SHBG as cortisol-induced IR and hyperinsulinaemia,increasing FAI). Have Cushingnoid features

  • Useful Test: Overnight DST, 24h urine free cortisol

Acromegaly: Oligomenorrhoea, 40-80% hirsutism. Skin changes, headaches, peripheral loss of vision, enlarged jaw/hands/feet.

  • Useful Test: GH suppression test, IGF1, MRI pituitary

Adrenal and ovarian androgen-secreting tumours: Potentially life-threatening. Rapid virilization (clitoromegaly, vocal deepening, frontal balding, muscular hypertrophy). Extremely high androgen levels, e.g. testosterone levels >5 nmol/L

  • Useful Tests: Testosterone (MS assay), DHEAS, Androstenedione, US ovaries, MRI adrenals

Ovarian hyperthecosis: Non-malignant luteinized thecal cells in the ovarian stroma secrete testosterone. Peri-menopausal. Serum testosterone higher than PCOS

Severe insulin resistance: Diabetes, Obesity, Hyperlipidaemia

  • Useful Tests: HOMA-IR (insulin, glucose)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are drugs causing PCOS type features?

A

Differentiating Features

  • Hirsutism: steroids, androgens, progestogens,danazol
  • Non-androgenic pattern hypertrichosis: valproate, phenytoin, minoxidil, ciclosporin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
A

Suggestive Features

  • Lower likelihood of anovulation and PCO prevalence (24%) than in PCOS (90%)
  • Useful test: Urine steroid metabolites and 17-OHP (basal + stimulated)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are differences between prolactin excess and PCOS?

A

Suggestive features

  • Prevalence of PCO/PCOS and identification of underlying mechanisms with different causes of hyperprolactinaemia poorly evaluated

Useful Test: Prolactin (↑ in 10-25% of PCOS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is involved in the aetiology of PCOS?

A
  • Hypothalamic
  • Pituitary
  • Ovarian
  • Metabolic
  • Sympathetic nervous system
  • Genetic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the results of faulty regulation of GnRH pulse generator?

A
  • GnRH pulse generator resists negative feedback of progesterone (mediated by androgen excess)
  • Resulting high GnRH pulse frequencies favours production of LH versus FSH beta-subunits
  • Relative LH excess drives ovarian steroidogenesis (increased androgen synthesis)
  • Excess androgens interfere with normal follicular development
  • Anovulation leads to low progesterone levels, limiting negative feedback on GnRH pulse generator
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How is PCOS investigated?

A

Clinical evaluation

  • Physical examination, history

Radiological

  • Ultrasound scan of ovaries

Biochemical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the scoring system for PCOS?

A

Ferriman-Gallwey scoring system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What does a typical ovarian ultrasound show?

A
  • Thickened capsule
  • Multiple 3-5 mm cysts
  • Hyperechogenic stroma
  • May also reveal virilizing ovarian tumours
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How PCOS biochemically investigated?

A
  • Gonadotrophins + E2 (increased LH:FSH with low E2 is classic but not often seen)
  • Prolactin (mild hyperprolactinaemia common)
  • Testosterone (MS assay) + SHBG
  • Androstenedione + DHEAS: Frequently slightly elevated (higher levels seen in CAH and virilizing tumours)
  • 17-OHP: Elevated in late-onset CAH (may require ACTH stimulation test)
  • Anti-mullerian hormone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How is Testosterone tested for and interperated in PCOS?

A
  • Total testosterone often elevated (higher levels seen in virilizing tumours)
  • Patients with hirsutism and normal testosterone frequently have low SHBG
  • Free androgen index = 100 x (Testo/SHBG)
  • Normal range not well evaluated, <4.5% generally used
17
Q

What are the features of androstenedione that make it clinically significant?

A

AD predicts metabolic risk

  • Strong negative association between AD and insulin sensitivity
  • Incidence of dysglycaemia increased with severity of androgen phenotype

AD is a sensitive indicator of androgen excess

  • PCOS had higher levels than controls
  • All 56 subjects with ↑T also had ↑AD
  • 20 had ↑AD with normal T

Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione

18
Q

What is Anti-Mullerian Hormone?

A
  • Glycoprotein produced by granulosa cells of the ovary in folliculogenesis
  • Small antral follicles make highest levels
  • Development switches to FSH-dependent after selection of dominant follicle
  • Regulates follicular growth initiation
19
Q

How does AMH regulate follicle growth initiation?

A
  • Inhibits early follicular recruitment preventing premature exhaustion of oocyte pool
  • Inhibits cyclic follicular recruitment by reducing sensitivity to FSH
  • Inhibits FSH-induced pre antral follicle growth
  • Reduces the number of LH receptors in granulosa cells induced by FSH
  • Inhibits FSH-induced CYP19a1 expression leading to reduced E2 levels (E2 inhibits AMH expression)
20
Q

How does Follicular arrest happen in PCOS?

A
  • FSH stimulates AMH and E2 in granulosa cells of small and large antral follicles
  • In small follicles, AMH inhibits aromatase, impairing E2 production
  • When E2 reaches a threshold in large antral follicles, AMH is inhibited through ERβ receptors, overcoming FSH and switching from AMH to E2 tone
  • In large follicles from PCO, the lack of FSH-induced E2 production and the high level of AMH impair the shift from the AMH to the E2 tone, causing follicular arrest
21
Q

What is the significance of Anti-Mullerian Hormone in PCOS?

A
  • High AMH levels in PCOS (multiple small follicles – surrogate marker for AFC)
  • Correlates with ovarian dysfunction, androgenaemia and clinical signs
  • High diagnostic specificity and sensitivity
  • High levels predictive of more challenging therapeutic management
22
Q

What are drawbacks of using AMH in PCOS?

A

No universal diagnostic threshold at present

  • Highly variable ultrasound inclusion criteria for PCOS in clinical studies
  • Awaiting international standard for serum AMH assay
23
Q

What are therapeutic options for PCOS?

A

Weight loss (Only if overweight)

  • ↓ Androgens but uncertain effect on hirsutism
  • Improved cardiovascular risk
  • May improve ovulation + endometrial protection

Mechanical hair removal

  • ↓ Hirsutism

Combined OCP

  • ↓ Androgens but uncertain effect on hirsutism
  • Suppression of ovulation and Endometrial protection
  • 1st line for menstrual abnormalities and hirsutism/acne, 6 months to see improvement

Cyproterone acetate

  • ↓ Clinical androgenisation
  • Anti-androgen (use with OCP)

Spironolactone

  • ↓ Clinical androgenisation
  • Anti-androgen (use with OCP)
  • Pregnancy must be avoided, Electrolyte effects (diuretic)

Metformin

  • ↓ Androgens but uncertain effect on hirsutism
  • May improve ovulation + endometrial protection
  • ↓ Metabolic/glycaemic abnormalities
  • Improving menstrual irregularities, but it has limited or no benefit in treating hirsutism, acne, or infertility

Clomiphene citrate

  • Ovulation induction
  • 1st line for fertility

Ovarian drilling

  • Ovulation induction
  • 2nd line for fertility

CVD monitoring also required